Chief Financial And Operating Officer
Us
CardioDynamics developed and marketed proprietary state-of-the-art noninvasive cardiac output monitoring systems. Annual revenues as high as $40M+. Strategic sale to SonoSite Inc. in August, 2009 with annual revenues of $250M. Managed relocation and integration of CardioDynamics operations and administration to SonoSite facility in Seattle. Oversee Finance and Accounting, Manufacturing, Materials, Human Resources, IT, Quality, Purchasing, Facilities, Tax, SEC Reporting, Risk Management, Internal Audit, Sarbanes-Oxley Compliance, Legal, Contracts and Investor Relations. Accomplishments- Key player in strategic sale of the Company at 69% market premium- Raised over $60M in public equity and debt financings- Moved from OTC to Small Cap to Nasdaq National Market- Obtained $4M bridge loan & $5M bank line- Implemented integrated ERP system- Spearheaded $14.6M of cost savings in 8 years- Managed 2 acquisitions & 1 divestitureKeywords: Impedance Cardiography, ICG, diagnostics, Biotech, Life Science, Vermed, Medis, PIPES, Secondary Public Offering, IPO, convertible note, derivative securities, foreign exchange, FAS 123R, stock option administration, investor relations, press releases, analyst, supply management, hardware, software, budgets, financial analysis, cost accounting, product costing, financial management, pricing, modeling, BDO Seidman, KPMG, CBIS Mayer Hoffman, Fourth Shift, Manage 2000, M2K, SalesForce.com, Concur, Section 16, Form 10-K, 10-Q, Proxy, SOX, MRP, JIT, ISO-9001, EN-4601, CE Mark, CMS, Medicare, FDA, Fast 50, strategic alliances, M&A, GE Healthcare, Philips, Mindray